How to As­sess Patent In­fringe­ment Properly

A competitor’s patent let­ter, a new­ly iden­ti­fied patent fam­i­ly or an im­pend­ing prod­uct launch can cre­ate im­me­di­ate pres­sure. Know­ing how to as­sess patent in­fringe­ment turns that pres­sure into a struc­tured tech­ni­cal and com­mer­cial de­ci­sion. The ques­tion is not whether two prod­ucts ap­pear sim­i­lar. The ques­tion is whether a spe­cif­ic prod­uct, process or use falls with­in the legal­ly rel­e­vant scope of one or more en­force­able patent claims in the rel­e­vant territory.

An ef­fec­tive as­sess­ment com­bines claim analy­sis, en­gi­neer­ing ev­i­dence and pro­ce­dur­al aware­ness. It should iden­ti­fy gen­uine ex­po­sure ear­ly, dis­tin­guish it from su­per­fi­cial over­lap, and pre­serve a clear ev­i­dence trail should ne­go­ti­a­tions or pro­ceed­ings follow.

Start with the right patent and the right territory

Patent rights are ter­ri­to­r­i­al. A Eu­ro­pean patent, for ex­am­ple, does not au­to­mat­i­cal­ly cre­ate a sin­gle en­force­able right across Eu­rope. Its sta­tus, val­i­da­tion and scope must be con­sid­ered in each coun­try where the rel­e­vant acts take place. Those acts may in­clude mak­ing, us­ing, of­fer­ing, sell­ing, im­port­ing or ap­ply­ing a patent­ed process.

Be­gin by con­firm­ing the patent num­ber, patent fam­i­ly mem­bers, le­gal sta­tus and rel­e­vant na­tion­al rights. Check whether the patent is grant­ed, pend­ing, ex­pired, lapsed, op­posed, lim­it­ed or re­voked. A pub­lished ap­pli­ca­tion can af­fect com­mer­cial plan­ning even where it is not yet en­force­able, while an ex­pired patent may still mat­ter when his­toric con­duct is alleged.

The lo­ca­tion of man­u­fac­ture, as­sem­bly, sale and de­liv­ery also mat­ters. A prod­uct made out­side the Unit­ed King­dom but im­port­ed into it may cre­ate a dif­fer­ent risk pro­file from a prod­uct made and sold sole­ly else­where. For in­ter­na­tion­al prod­uct pro­grammes, as­sess each com­mer­cial­ly ma­te­r­i­al ju­ris­dic­tion sep­a­rate­ly rather than as­sum­ing that one con­clu­sion ap­plies everywhere.

How to as­sess patent in­fringe­ment through the claims

The claims de­fine the le­gal bound­ary of a patent. The de­scrip­tion, draw­ings and pros­e­cu­tion his­to­ry can as­sist in­ter­pre­ta­tion, but an in­fringe­ment as­sess­ment starts and ends with the claims as con­strued un­der the ap­plic­a­ble law.

Read the in­de­pen­dent claims first. They usu­al­ly set out the broad­est claimed com­bi­na­tion, such as a de­vice with par­tic­u­lar com­po­nents, a method with de­fined steps, or a sys­tem con­fig­ured to per­form a spec­i­fied func­tion. De­pen­dent claims add fur­ther lim­i­ta­tions and may still be com­mer­cial­ly sig­nif­i­cant if the in­de­pen­dent claim is not in­fringed or is vul­ner­a­ble to challenge.

For each claim, sep­a­rate the re­quired fea­tures into clear tech­ni­cal el­e­ments. This pro­duces a claim chart or fea­ture map. A sim­ple de­vice claim may re­quire a hous­ing, a sen­sor, a proces­sor con­fig­ured in a par­tic­u­lar way, and a de­fined re­la­tion­ship be­tween those el­e­ments. A method claim may re­quire steps to oc­cur in a par­tic­u­lar or­der or un­der de­fined op­er­at­ing conditions.

The cen­tral rule is de­mand­ing but use­ful: every re­quired fea­ture must be present for lit­er­al in­fringe­ment of a claim. If a manda­to­ry el­e­ment is ab­sent, the claim is gen­er­al­ly not lit­er­al­ly in­fringed. Prod­uct sim­i­lar­i­ty alone is not enough.

That does not end the analy­sis. In some ju­ris­dic­tions, a prod­uct that does not re­pro­duce the pre­cise claim lan­guage may still cre­ate risk un­der prin­ci­ples con­cern­ing equiv­a­lents. The ap­pli­ca­tion of equiv­a­lents is fact-spe­cif­ic and varies by ju­ris­dic­tion. It re­quires care­ful con­sid­er­a­tion of the tech­ni­cal ef­fect, the sig­nif­i­cance of the vari­a­tion and what a skilled per­son would un­der­stand from the patent. It should not be treat­ed as a short­cut around dis­ci­plined claim analysis.

Map the ac­tu­al prod­uct, not the mar­ket­ing description

A re­li­able claim chart uses ev­i­dence from the ac­tu­al prod­uct or process. Mar­ket­ing brochures may be in­com­plete, as­pi­ra­tional or de­lib­er­ate­ly gen­er­al. The strongest analy­sis draws on en­gi­neer­ing draw­ings, spec­i­fi­ca­tions, bills of ma­te­ri­als, source code, test data, man­u­fac­tur­ing records, op­er­at­ing man­u­als and, where ap­pro­pri­ate, in­spec­tion or re­verse-en­gi­neer­ing findings.

This is par­tic­u­lar­ly im­por­tant where a claim uses func­tion­al lan­guage, such as a com­po­nent “con­fig­ured to” per­form an ac­tion. The rel­e­vant is­sue may be what the prod­uct is ob­jec­tive­ly ca­pa­ble of do­ing, not mere­ly what users nor­mal­ly do with it. Con­verse­ly, a claimed method may re­quire proof that par­tic­u­lar steps are ac­tu­al­ly performed.

Each fea­ture should be marked as present, ab­sent, un­cer­tain or re­quir­ing fur­ther ev­i­dence. Avoid fill­ing gaps with as­sump­tions. A clear “un­known” can be more valu­able than an un­sup­port­ed con­clu­sion be­cause it iden­ti­fies pre­cise­ly what tech­ni­cal work, doc­u­ment re­quest or prod­uct test­ing is need­ed next.

In­ter­pret un­cer­tain claim lan­guage carefully

Patent claims of­ten con­tain terms that ap­pear or­di­nary but car­ry a spe­cialised tech­ni­cal mean­ing. Words such as “sub­stan­tial­ly”, “cou­pled”, “aligned”, “about” or “re­spon­sive to” may need in­ter­pre­ta­tion in the con­text of the whole patent and the skilled person’s com­mon gen­er­al knowl­edge at the pri­or­i­ty date.

Do not as­sess a claim fea­ture in iso­la­tion. Re­view the de­scrip­tion and draw­ings to un­der­stand how the patent uses the term, then com­pare that con­struc­tion against the prod­uct ev­i­dence. A nar­row in­ter­pre­ta­tion may elim­i­nate ap­par­ent over­lap. A broad­er in­ter­pre­ta­tion may ex­pose a risk that was not vis­i­ble in an ini­tial tech­ni­cal review.

The as­sess­ment must also dis­tin­guish es­sen­tial lim­i­ta­tions from back­ground state­ments. A sen­tence in the de­scrip­tion is not au­to­mat­i­cal­ly a claim re­quire­ment, and a prod­uct need not copy a pre­ferred em­bod­i­ment to in­fringe. This is where patent ex­per­tise and prac­ti­cal en­gi­neer­ing un­der­stand­ing must work together.

Con­sid­er the type of in­fringe­ment alleged

Di­rect in­fringe­ment is only one pos­si­bil­i­ty. De­pend­ing on the ju­ris­dic­tion and cir­cum­stances, sup­ply­ing a means that is suit­able and in­tend­ed for putting a patent­ed in­ven­tion into ef­fect may cre­ate in­di­rect or con­trib­u­to­ry in­fringe­ment risk. This is rel­e­vant for com­po­nent sup­pli­ers, plat­form providers and busi­ness­es sell­ing prod­ucts de­signed to be com­bined with oth­er equipment.

Method claims need sep­a­rate at­ten­tion. A de­vice may be sold law­ful­ly while its op­er­a­tion by a cus­tomer per­forms a patent­ed method. Con­verse­ly, a claimed process car­ried out en­tire­ly abroad may not have the same con­se­quences as a process per­formed in the tar­get mar­ket. The facts, the claim word­ing and na­tion­al law de­ter­mine the answer.

A fur­ther dis­tinc­tion is com­mer­cial rel­e­vance. A tech­ni­cal­ly ar­guable claim may not jus­ti­fy im­me­di­ate re­design if the patent is near ex­piry, the as­sert­ed mar­ket is small or a li­cence is com­mer­cial­ly at­trac­tive. Equal­ly, a claim with un­cer­tain in­fringe­ment may war­rant ur­gent ac­tion when an in­junc­tion could dis­rupt a ma­jor launch.

Test en­force­abil­i­ty and va­lid­i­ty along­side infringement

An in­fringe­ment view is in­com­plete if it ig­nores whether the claim is like­ly to be en­force­able. A patent is pre­sumed valid in many set­tings, but that does not make it im­mune from chal­lenge. Ear­li­er pub­li­ca­tions, pub­lic uses, pri­or sales and in­suf­fi­cient dis­clo­sure may af­fect va­lid­i­ty. Added mat­ter, lack of in­ven­tive step and clar­i­ty is­sues can also be rel­e­vant, de­pend­ing on the ju­ris­dic­tion and pro­ce­dur­al route.

Va­lid­i­ty analy­sis is not a li­cence to dis­re­gard an ac­tive patent. Un­til a patent is lim­it­ed or re­voked through the ap­pro­pri­ate process, com­mer­cial de­ci­sions should ac­count for the risk it may be en­forced. Nev­er­the­less, iden­ti­fy­ing cred­i­ble va­lid­i­ty ar­gu­ments changes ne­go­ti­a­tion lever­age, lit­i­ga­tion strat­e­gy and the val­ue of a design-around.

It is also es­sen­tial to keep in­fringe­ment and va­lid­i­ty analy­ses sep­a­rate in the work­ing pa­pers. “We do not in­fringe” and “the claim is in­valid” are dif­fer­ent propo­si­tions sup­port­ed by dif­fer­ent ev­i­dence. A dis­ci­plined file makes the busi­ness po­si­tion clear­er and sup­ports ex­ter­nal patent at­tor­neys if for­mal pro­ceed­ings be­come necessary.

Trans­late find­ings into a decision

The fi­nal de­liv­er­able should not be a pile of marked-up claims. It should state which claims present risk, why they do or do not read onto the prod­uct, what ev­i­dence sup­ports the con­clu­sion, and where un­cer­tain­ty re­mains. It should also iden­ti­fy prac­ti­cal op­tions: re­design­ing a fea­ture, chang­ing a process step, ob­tain­ing a li­cence, chal­leng­ing the patent, de­lay­ing a launch, or ac­cept­ing a mea­sured risk.

For a de­sign-around, as­sess the re­vised tech­ni­cal so­lu­tion against the claims be­fore com­mit­ting to tool­ing, soft­ware de­vel­op­ment or reg­u­la­to­ry work. A mi­nor al­ter­ation that does not re­move a re­quired claim fea­ture may pro­vide no mean­ing­ful pro­tec­tion. A well-de­signed al­ter­na­tive can re­duce risk while pre­serv­ing prod­uct per­for­mance and com­mer­cial value.

TIPAG de­liv­ers struc­tured in­fringe­ment analy­sis that con­nects claim lan­guage with the tech­ni­cal re­al­i­ty of a prod­uct, process or sys­tem. Where le­gal rep­re­sen­ta­tion or for­mal pro­ce­dur­al ad­vice is re­quired, in­de­pen­dent patent at­tor­neys can be en­gaged with a clear tech­ni­cal record and de­fined questions.

The most use­ful time to as­sess patent in­fringe­ment is be­fore a prod­uct de­ci­sion be­comes ex­pen­sive to re­verse. Bring the claims, the prod­uct ev­i­dence and the com­mer­cial ob­jec­tive into the same re­view, then act on the facts rather than on re­sem­blance or assumption.